F18 RADIOPHARMACEUTICALS

The Department of Veterans Affairs plans to issue a solicitation for the daily delivery of various F-18 PET radiopharmaceuticals, including FDG, NaF-F18, beta-amyloid imaging agents, and several other specialized F18-based compounds, to the Nuclear Medicine Service at the Atlanta VA Medical Center in Decatur, Georgia. The contract requires the vendor to provide all necessary labor, supervision, and transportation to ensure timely delivery. The anticipated contract performance period is expected to start on March 20, 2026, with an initial base year and four additional option years, subject to government exercise. This solicitation is set aside exclusively for small businesses under the SBA program and falls under NAICS code 325412. Interested and responsible vendors must be registered and active in the System for Award Management (SAM) at the time of proposal submission, which is due by March 3, 2026. Failure to be registered will result in a non-responsive proposal. The solicitation and related information will be posted on SAM.gov by the Department of Veterans Affairs’ Network Contract Office 7, headquartered in Augusta, Georgia, with Natasha Mixon as the primary point of contact.